Skip to content
Home/Companies/Healthcare/Soteria Biotherapeutics
Soteria Biotherapeutics

Soteria Biotherapeutics

Healthcare·US·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Soteria Biotherapeutics?

Soteria Biotherapeutics is currently owned by Abingworth through Abingworth Bioventures VII (2018 vintage), since 2021.

Hand-verified · updated 2026-06-10

Abingworth
Investor
Abingworth
Abingworth Bioventures VII · 2018 · Life Sciences VC

Key facts

HQUS
SectorHealthcare
StatusActive
Websitesoteriabiotherapeutics.com

More from Abingworth Bioventures VII

Other portfolio companies in the same fund.

Adicet Bio
Adicet Bio
Active
BiotechUS· 2021
Atsena Therapeutics
Atsena Therapeutics
Active
BiotechUS· 2020
Orbus Therapeutics
Orbus Therapeutics
Active
HealthcareUS· 2020
Q32 Bio
Exited 2024
BiotechUS· 2020
Scorpion Therapeutics
Scorpion Therapeutics
Exited 2025
BiotechUS· 2020
to
Spruce Biosciences
Spruce Biosciences
Exited 2020
BiotechUS· 2020

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Soteria Biotherapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Soteria Biotherapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue